Vessi Medical
vessimed.com
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$16.5M
1 round on record
Latest round
$16.5M
Series A · Feb 2024 · 2 yr ago
Team
51-200
employees, estimated range
Backers
1
The Trendlines Group
The money's age
Long since its last round
32 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Feb 13, 2024
Raised a round Series A $16.5M
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series A | Feb 2024 | $16.5M | — | medindia.net |
Backed byfrom the funds' portfolios and accelerator catalogs
The Trendlines Group Investors in similar startupsfunds that back the companies most like this one
backs Frontier Bio
Similar startupsby what they do, their industry and backers
CoreBone offers tissue regeneration solutions for Bone and Cartilage from cultivated corals.
Alveron Pharma is developing a unique coagulationplatform technology with the world.
株式会社エアメンブレンは、グラフェンTEMグリッド・グラフェンシートなど二次元材料の合成・製品化を行うつくば発の研究開発型企業です。クライオ電子顕微鏡（cryo-EM）向け支持膜でタンパク質構造解析を支えます。.
Draupnir Bio is developing new innovative therapies for patients.
Avidicure is developing dual agonistic avidity-engineered multifunctional antibodies, AVC-Boosters, as monotherapy for treatment of cancer.
Uniting brands and fans. Custom AI trained on your brand’s DNA, empowering fans, creators, and teams to instantly create on-brand…
News
Vessi Medical: Urology Medical Device Company Secures $16.5 Million
Vessi Medical announced that it has closed a Series A financing round of $16.5 million for its cryotherapy technology to treat Non Muscle Invasive Bladder Cancer (NMIBC). The leading investors in the round are an undisclosed global strategic investor, ALI
Read more
Report
Cryotherapy technology company Vessi Medical scores $16.5M and more digital health fundings
Read more
Report
Vessi Medical Closes $16.5 Million Series A Round for Innovative Cryotherapy Bladder Cancer Treatment
Read more
Report
Vessi Medical Closes $16.5 Million Series A Round for Innovative Cryotherapy Bladder Cancer Treatment
Read more
Report
First in Human Procedure with Vessi Medical
MISGAV, Israel, July 14, 2021/ PRNewswire/-- Vessi Medical, announced that it successfully completed a first-in-human case with its minimally invasive cryoablation solution for superficial bladder cancer. The procedure was performed at Rambam Healthcare C
Read more
Report
Report
Vessi Medical Reaps $1.7 Million in Funding for Minimally Invasive Bladder Cancer Treatment
/PRNewswire/ -- Vessi Medical, a portfolio company of The Trendlines Group Ltd. (SGX: 42T) (OTCQX: TRNLY) announced that it secured $1.7 million in funding for...
Read more
Report
Financials
Total raised
$16.5M
Latest round
Series A
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Series A | 2024 | $16.5M | Details |